Surge in Options Trading: Clorox, L3Harris, and Ulta Beauty See High Volume

Strong Activity Shifts in Major Stocks

Today, activity within the Russell 3000 index indicates a significant increase in options trading for Clorox Co (Symbol: CLX). A total of 6,190 contracts have been traded, equating to approximately 619,000 underlying shares. This represents about 48.3% of CLX’s average daily trading volume, which stands at 1.3 million shares over the past month. Notably, the $165 strike call option set to expire on December 06, 2024, has garnered particular interest, with 3,480 contracts traded today, covering around 348,000 underlying shares. Below is a chart summarizing CLX’s trading history over the past twelve months, highlighting the $165 strike in orange:

Similarly, L3Harris Technologies Inc (Symbol: LHX) recorded an options trading volume of 3,633 contracts, or about 363,300 underlying shares. This amount corresponds to roughly 47.8% of LHX’s average daily trading volume, which totals 760,610 shares for the last month. The $270 strike call option, expiring on December 20, 2024, saw notable action, with 1,372 contracts traded today, representing around 137,200 underlying shares. Below is a chart showing LHX’s trading history for the past twelve months, with the $270 strike highlighted:

Ulta Beauty Inc (Symbol: ULTA) has also experienced strong options trading today, with a total volume of 4,851 contracts. This represents about 485,100 underlying shares, totaling 47.8% of ULTA’s average daily trading volume of 1.0 million shares over the past month. The $397.50 strike call option, which expires on November 15, 2024, was particularly active, seeing 436 contracts traded, equivalent to approximately 43,600 underlying shares. Below is a chart for ULTA’s trading history, with the $397.50 strike highlighted:

For a comprehensive look at the available options for CLX, LHX, or ULTA, check out StockOptionsChannel.com.

Today’s Most Active Call & Put Options of the S&P 500 »

Also see:

• IGK Videos
• WMGI Videos
• GOSS Insider Buying

The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.